Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 2
1994 3
1995 2
1996 1
1997 2
1998 1
1999 1
2003 3
2005 1
2007 2
2008 3
2009 2
2010 3
2011 5
2012 2
2013 4
2014 7
2015 7
2016 6
2017 7
2018 4
2019 2
2020 7
2021 4
2022 3
2023 5
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Translational cancer biology.
Maccalli C. Maccalli C. J Transl Med. 2020 Sep 23;18(1):364. doi: 10.1186/s12967-020-02537-z. J Transl Med. 2020. PMID: 32967699 Free PMC article. No abstract available.
Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironment.
Wang Y, Drum DL, Sun R, Zhang Y, Chen F, Sun F, Dal E, Yu L, Jia J, Arya S, Jia L, Fan S, Isakoff SJ, Kehlmann AM, Dotti G, Liu F, Zheng H, Ferrone CR, Taghian AG, DeLeo AB, Ventin M, Cattaneo G, Li Y, Jounaidi Y, Huang P, Maccalli C, Zhang H, Wang C, Yang J, Boland GM, Sadreyev RI, Wong L, Ferrone S, Wang X. Wang Y, et al. Among authors: maccalli c. Nat Commun. 2023 Sep 15;14(1):5727. doi: 10.1038/s41467-023-41282-x. Nat Commun. 2023. PMID: 37714830 Free PMC article.
Editorial: Engineered immune cells in cancer immunotherapy (EICCI).
Martin F, Schambach A, Maccalli C. Martin F, et al. Among authors: maccalli c. Front Immunol. 2022 Dec 20;13:1119363. doi: 10.3389/fimmu.2022.1119363. eCollection 2022. Front Immunol. 2022. PMID: 36605186 Free PMC article. No abstract available.
Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi.
Cavazza A, Hendel A, Bak RO, Rio P, Güell M, Lainšček D, Arechavala-Gomeza V, Peng L, Hapil FZ, Harvey J, Ortega FG, Gonzalez-Martinez C, Lederer CW, Mikkelsen K, Gasiunas G, Kalter N, Gonçalves MAFV, Petersen J, Garanto A, Montoliu L, Maresca M, Seemann SE, Gorodkin J, Mazini L, Sanchez R, Rodriguez-Madoz JR, Maldonado-Pérez N, Laura T, Schmueck-Henneresse M, Maccalli C, Grünewald J, Carmona G, Kachamakova-Trojanowska N, Miccio A, Martin F, Turchiano G, Cathomen T, Luo Y, Tsai SQ, Benabdellah K; COST Action CA21113. Cavazza A, et al. Among authors: maccalli c. Mol Ther Nucleic Acids. 2023 Oct 29;34:102066. doi: 10.1016/j.omtn.2023.102066. eCollection 2023 Dec 12. Mol Ther Nucleic Acids. 2023. PMID: 38034032 Free PMC article. Review.
Peptide-based vaccines for cancer therapy.
Parmiani G, Russo V, Maccalli C, Parolini D, Rizzo N, Maio M. Parmiani G, et al. Among authors: maccalli c. Hum Vaccin Immunother. 2014;10(11):3175-8. doi: 10.4161/hv.29418. Hum Vaccin Immunother. 2014. PMID: 25483658 Free PMC article. Review.
Defining the critical hurdles in cancer immunotherapy.
Fox BA, Schendel DJ, Butterfield LH, Aamdal S, Allison JP, Ascierto PA, Atkins MB, Bartunkova J, Bergmann L, Berinstein N, Bonorino CC, Borden E, Bramson JL, Britten CM, Cao X, Carson WE, Chang AE, Characiejus D, Choudhury AR, Coukos G, de Gruijl T, Dillman RO, Dolstra H, Dranoff G, Durrant LG, Finke JH, Galon J, Gollob JA, Gouttefangeas C, Grizzi F, Guida M, Håkansson L, Hege K, Herberman RB, Hodi FS, Hoos A, Huber C, Hwu P, Imai K, Jaffee EM, Janetzki S, June CH, Kalinski P, Kaufman HL, Kawakami K, Kawakami Y, Keilholtz U, Khleif SN, Kiessling R, Kotlan B, Kroemer G, Lapointe R, Levitsky HI, Lotze MT, Maccalli C, Maio M, Marschner JP, Mastrangelo MJ, Masucci G, Melero I, Melief C, Murphy WJ, Nelson B, Nicolini A, Nishimura MI, Odunsi K, Ohashi PS, O'Donnell-Tormey J, Old LJ, Ottensmeier C, Papamichail M, Parmiani G, Pawelec G, Proietti E, Qin S, Rees R, Ribas A, Ridolfi R, Ritter G, Rivoltini L, Romero PJ, Salem ML, Scheper RJ, Seliger B, Sharma P, Shiku H, Singh-Jasuja H, Song W, Straten PT, Tahara H, Tian Z, van Der Burg SH, von Hoegen P, Wang E, Welters MJ, Winter H, Withington T, Wolchok JD, Xiao W, Zitvogel L, Zwierzina H, Marincola FM, Gajewski TF, Wigginton JM, Dis… See abstract for full author list ➔ Fox BA, et al. Among authors: maccalli c. J Transl Med. 2011 Dec 14;9:214. doi: 10.1186/1479-5876-9-214. J Transl Med. 2011. PMID: 22168571 Free PMC article.
Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications.
Roelands J, Kuppen PJK, Vermeulen L, Maccalli C, Decock J, Wang E, Marincola FM, Bedognetti D, Hendrickx W. Roelands J, et al. Among authors: maccalli c. Int J Mol Sci. 2017 Oct 24;18(10):2229. doi: 10.3390/ijms18102229. Int J Mol Sci. 2017. PMID: 29064420 Free PMC article. Review.
Reverting Immune Suppression to Enhance Cancer Immunotherapy.
Guerrouahen BS, Maccalli C, Cugno C, Rutella S, Akporiaye ET. Guerrouahen BS, et al. Among authors: maccalli c. Front Oncol. 2020 Jan 21;9:1554. doi: 10.3389/fonc.2019.01554. eCollection 2019. Front Oncol. 2020. PMID: 32039024 Free PMC article. Review.
Cancer stem cells: perspectives for therapeutic targeting.
Maccalli C, De Maria R. Maccalli C, et al. Cancer Immunol Immunother. 2015 Jan;64(1):91-7. doi: 10.1007/s00262-014-1592-1. Epub 2014 Aug 8. Cancer Immunol Immunother. 2015. PMID: 25104304 Free PMC article. Review.
77 results